推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 “十三五”期間商洛市中藥材基地總面積發(fā)展到200萬畝以上，建設(shè)道地中藥材規(guī)范化生產(chǎn)基地80萬畝；引進建設(shè)年產(chǎn)值在千萬元以上的醫(yī)藥加工、營銷企業(yè)10個，培育發(fā)展產(chǎn)值億元以上的醫(yī)藥龍頭企業(yè)15個，產(chǎn)值過10億元的企業(yè)達到5家，發(fā)展壯大商丹、山陽、柞水3大醫(yī)藥產(chǎn)業(yè)聚集區(qū)，加快建設(shè)“商洛國家級中藥材戰(zhàn)略儲備庫”，推進中藥材倉儲物流及交易體系建設(shè)，打造中醫(yī)藥產(chǎn)業(yè)集群。加快道地藥材認(rèn)證、基地規(guī)范化認(rèn)證、地理標(biāo)志認(rèn)證和制藥企業(yè)的GMP認(rèn)證步伐，進一步唱響“商藥”品牌。中醫(yī)藥產(chǎn)業(yè)總產(chǎn)值達300億元以上，把商洛市打造成為國家西部新醫(yī)藥教育培訓(xùn)、研發(fā)制造、倉儲物流和中藥現(xiàn)代化產(chǎn)業(yè)基地。
今年商洛市中藥產(chǎn)業(yè)發(fā)展將以提質(zhì)增效和促進藥農(nóng)增收為重點，大力發(fā)展十大中藥材基地，積極推行訂單種植。全年新發(fā)展中藥材面積22.5萬畝，建設(shè)中藥材示范基地7.5萬畝，實施野生木本藥材撫育9萬畝，重點培育30個規(guī)?；痉痘兀兄兴幉目偖a(chǎn)量達到50萬噸，中醫(yī)藥產(chǎn)業(yè)總產(chǎn)值達到100億元。
